DTCCX
Price
$15.95
Change
+$0.08 (+0.50%)
Updated
Oct 17 closing price
Net Assets
504.59M
VTSMX
Price
$159.25
Change
+$0.69 (+0.44%)
Updated
Oct 17 closing price
Net Assets
2.02T
Interact to see
Advertisement

DTCCX vs VTSMX

Header iconDTCCX vs VTSMX Comparison
Open Charts DTCCX vs VTSMXBanner chart's image
BNY Mellon Sust US Equity C
Price$15.95
Change+$0.08 (+0.50%)
VolumeN/A
Net Assets504.59M
Vanguard Total Stock Mkt Idx I
Price$159.25
Change+$0.69 (+0.44%)
VolumeN/A
Net Assets2.02T
DTCCX vs VTSMX Comparison Chart in %
View a ticker or compare two or three
VS
DTCCX vs. VTSMX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCCX is a Hold and VTSMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 2.02T vs. DTCCX (505M). VTSMX pays higher dividends than DTCCX: VTSMX (1.04) vs DTCCX (0.00). DTCCX was incepted earlier than VTSMX: DTCCX (26 years) vs VTSMX (34 years). DTCCX (1.86) is less costly to investors than VTSMX (0.14). DTCCX is a more actively managed with annual turnover of: 27.23 vs. VTSMX (2.00). DTCCX has a lower initial minimum investment than VTSMX: DTCCX (1000) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 13.79 vs. DTCCX (2.04). VTSMX return over 5 years is better than : 84.86 vs. DTCCX (25.53).
DTCCXVTSMXDTCCX / VTSMX
Total Expense Ratio1.700.141,214%
Annual Report Gross Expense Ratio1.860.141,329%
Fund Existence26 years34 years-
Gain YTD11.85113.01291%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets505M2.02T0%
Annual Yield % from dividends0.001.04-
Returns for 1 year2.0413.7915%
Returns for 3 years33.2576.0244%
Returns for 5 years25.5384.8630%
Returns for 10 years33.10225.1015%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP3.700.27
+7.87%
Indaptus Therapeutics Inc
APPN28.150.36
+1.30%
Appian Corp
LITE164.771.54
+0.94%
Lumentum Holdings
MLR40.16-0.50
-1.23%
Miller Industries
LGO1.29-0.03
-2.27%
Largo